Research Management
The quality of research and transparency in the selection of funded projects and projects developed by our institutes are guaranteed by the peer review method, borrowed from international best practice.
We identify the most deserving projects with the greatest potential impact on patients’ lives through a research selection and funding process in which two parties, with fundamental and distinct roles, collaborate: the Research Program Managers and the Scientific Committee.
The Research Program Managers work in our Research Office: they manage the entire process, from the definition of the competitive calls for proposals for the allocation of funds to the research groups to the submission of the final evaluation report. They identify external reviewers, independent scientists with expertise in specific research fields to support the Members of the Scientific Committee in the evaluation of project proposals.
The role of the Research Program Managers is crucial, as they enable the separation between the evaluated and the evaluating subjects, thus guaranteeing rigor and objectivity.
The Scientific Committee Members play a central role in the evaluation of research projects, also with the support of external reviewers specially selected for each research project by the Research Program Managers.
In this way, we create the conditions for researchers to think about their own research without losing sight of the potential for therapy development that could result from it.
We ask them to set themselves concrete, short-term goals and put projects at the same stage of development in competition with each other, so as to incentivise commitment and give value to the feasibility of the projects.
The constant funding of research, be it basic or translational, i.e. oriented towards the development of therapies, it is essential to develop innovation to the point of identifying the most appropriate therapy pathways.
Research must be a collective asset: we are committed to sharing information and results for the advancement of research in the broadest sense, especially in the face of little-known or unknown pathologies such as rare genetic diseases. Clinical, genetic and biological data are made available to the scientific community with dedicated tools and services, such as biobanks and support for the creation of disease registries.
The initiatives
Discover the different initiatives through which we fund scientific research:
- Telethon Multi-round Call
- Fondazione Telethon-Fondazione Cariplo Joint Call for application
- Telethon-UILDM Call (in partnership with Unione Italiana Lotta alla Distrofia Muscolare)
- Seed Grant (in partnership with Patients Organisations)
- AriSLA – an agency focused on Amyiotrophic Lateral Sclerosis
